Mirati Therapeutics, Inc. Quarterly Current Ratio in % from Q3 2015 to Q3 2023

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Mirati Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q3 2015 to Q3 2023.
  • Mirati Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2023 was 695 %, a 32.4% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2023 695 -333 -32.4% Sep 30, 2023
Q2 2023 743 -285 -27.7% Jun 30, 2023
Q1 2023 844 -85.3 -9.18% Mar 31, 2023
Q4 2022 922 -82.3 -8.19% Dec 31, 2022
Q3 2022 1.03K -114 -9.95% Sep 30, 2022
Q2 2022 1.03K -127 -11% Jun 30, 2022
Q1 2022 930 -516 -35.7% Mar 31, 2022
Q4 2021 1K -325 -24.4% Dec 31, 2021
Q3 2021 1.14K +108 +10.4% Sep 30, 2021
Q2 2021 1.15K +19 +1.67% Jun 30, 2021
Q1 2021 1.45K +206 +16.6% Mar 31, 2021
Q4 2020 1.33K +100 +8.14% Dec 31, 2020
Q3 2020 1.03K -267 -20.5% Sep 30, 2020
Q2 2020 1.14K -122 -9.69% Jun 30, 2020
Q1 2020 1.24K +98.2 +8.6% Mar 31, 2020
Q4 2019 1.23K +148 +13.7% Dec 31, 2019
Q3 2019 1.3K +127 +10.8% Sep 30, 2019
Q2 2019 1.26K +195 +18.4% Jun 30, 2019
Q1 2019 1.14K +268 +30.6% Mar 31, 2019
Q4 2018 1.08K +215 +24.8% Dec 31, 2018
Q3 2018 1.17K +517 +78.6% Sep 30, 2018
Q2 2018 1.06K +414 +63.8% Jun 30, 2018
Q1 2018 874 +249 +39.8% Mar 31, 2018
Q4 2017 867 +232 +36.6% Dec 31, 2017
Q3 2017 657 -183 -21.8% Sep 30, 2017
Q2 2017 649 -414 -39% Jun 30, 2017
Q1 2017 625 -541 -46.4% Mar 31, 2017
Q4 2016 634 -620 -49.4% Dec 31, 2016
Q3 2016 840 -277 -24.8% Sep 30, 2016
Q2 2016 1.06K Jun 30, 2016
Q1 2016 1.17K Mar 31, 2016
Q4 2015 1.25K Dec 31, 2015
Q3 2015 1.12K Sep 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.